Protective Factors Associated With Lower Likelihood of Injection Drug Use and Experiencing Overdose Among Incarcerated Women.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Elsevier Science Publishing Country of Publication: United States NLM ID: 9101000 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4321 (Electronic) Linking ISSN: 10493867 NLM ISO Abbreviation: Womens Health Issues Subsets: MEDLINE
    • Publication Information:
      Publication: New York, NY : Elsevier Science Publishing
      Original Publication: New York, NY : Elsevier, c1990-
    • Subject Terms:
    • Abstract:
      Purpose: Prior studies evaluated protective factors individually as they relate to fewer drug use risk behaviors and related consequences. This is the first study to examine protective factors as part of a multilevel framework along a risk continuum among women involved in the criminal legal system who use drugs. This study describes factors within the socio-ecological framework that are protective against engaging in injection drug use and experiencing nonfatal overdose.
      Method: Data were collected from 900 women with a history of opioid use disorder who were incarcerated and enrolled in the National Institutes of Health/National Institute on Drug Abuse-funded Justice Community Opioid Innovation Network cooperative. Analysis focused on the relationship among individual, interpersonal, and community- or institutional-level protective factors associated with not injecting drugs and not experiencing an overdose in the 90 days before incarceration using multinomial logistic regression.
      Findings: Findings from this study suggest that, even among a sample of women who use drugs, there are a number of factors associated with being less likely to report higher-risk injection behavior and/or overdose experiences at the individual level (age, religiosity, and less polysubstance use), interpersonal level (not having a partner who injects drugs), and community or institutional level (fewer months incarcerated, less treatment utilization, and less enacted stigma by health care workers).
      Conclusions: Findings from this study underscore the importance of being able to target prevention interventions to women at different stages of substance use severity and to capitalize on protective factors for those at lower-risk levels to reduce the trajectory of risk of injection practices and overdose experiences.
      (Copyright © 2024 Jacobs Institute of Women's Health, George Washington University. Published by Elsevier Inc. All rights reserved.)
    • References:
      Int J Drug Policy. 2022 Feb;100:103534. (PMID: 34896932)
      Int J Drug Policy. 2021 May;91:102977. (PMID: 33129662)
      Drug Alcohol Depend. 2016 May 1;162:34-43. (PMID: 26972790)
      Pediatr Clin North Am. 2002 Apr;49(2):463-77. (PMID: 11993293)
      Int J Offender Ther Comp Criminol. 2014 Mar;58(3):303-19. (PMID: 23358104)
      MCN Am J Matern Child Nurs. 1998 Mar-Apr;23(2):99-104. (PMID: 9529873)
      Accid Anal Prev. 2022 Dec;178:106837. (PMID: 36130429)
      Am J Prev Med. 1998 May;14(4):245-58. (PMID: 9635069)
      Public Health. 2015 Jun;129(6):611-20. (PMID: 26025176)
      J Migr Health. 2023 Jan 24;7:100164. (PMID: 37398939)
      Drug Alcohol Depend. 2020 Apr 1;209:107890. (PMID: 32058246)
      J Psychoactive Drugs. 1999 Oct-Dec;31(4):353-62. (PMID: 10681102)
      Drug Alcohol Depend. 2005 Oct 1;80(1):35-43. (PMID: 16157229)
      Nordisk Alkohol Nark. 2023 Oct;40(5):502-519. (PMID: 37969903)
      Drug Alcohol Depend. 2013 Oct 1;132(3):603-9. (PMID: 23647731)
      J Stud Alcohol Drugs. 2023 Jul;84(4):508-519. (PMID: 36971761)
      Health Educ Q. 1988 Winter;15(4):351-77. (PMID: 3068205)
      J Child Adolesc Subst Abuse. 2020;29(1):46-57. (PMID: 33762805)
      Vulnerable Child Youth Stud. 2023;18(2):149-155. (PMID: 38076331)
      Front Rehabil Sci. 2022 Jan 17;2:710629. (PMID: 36188868)
      Subst Use Misuse. 2012 Jun-Jul;47(8-9):944-62. (PMID: 22676565)
      Addict Behav. 2012 Jul;37(7):747-75. (PMID: 22445418)
      J Addict Nurs. 2023 Jul-Sep 01;34(3):E65-E73. (PMID: 37669346)
      Subst Abuse Rehabil. 2023 Nov 13;14:131-145. (PMID: 38026785)
      Addict Behav. 2012 Jun;37(6):691-6. (PMID: 22385733)
      Soc Sci Med. 2004 May;58(10):2083-92. (PMID: 15020021)
      MMWR Suppl. 2023 Apr 28;72(1):37-44. (PMID: 37104464)
      Front Psychol. 2021 Jul 16;12:686414. (PMID: 34335400)
      Drug Alcohol Rev. 2016 Sep;35(5):620-7. (PMID: 26661408)
      Womens Health Issues. 2017 Nov - Dec;27(6):652-659. (PMID: 28882550)
      Am J Community Psychol. 2013 Mar;51(1-2):91-102. (PMID: 22392193)
      Drugs (Abingdon Engl). 2023;30(3):334-343. (PMID: 37587980)
      J Pers Assess. 1990 Winter;55(3-4):610-7. (PMID: 2280326)
      J Relig Health. 2018 Aug;57(4):1451-1457. (PMID: 29110202)
      Drug Alcohol Depend. 2023 Jun 1;247:109866. (PMID: 37062249)
      J Child Adolesc Psychopharmacol. 2019 Aug;29(7):487-497. (PMID: 31246496)
      Drug Alcohol Depend. 2007 Feb 23;87(1):63-8. (PMID: 16962254)
      J Rural Health. 2018 Dec;34(1):31-41. (PMID: 28685884)
      J Subst Abuse Treat. 2021 Sep;128:108284. (PMID: 33455828)
    • Grant Information:
      UG1 DA050069 United States DA NIDA NIH HHS
    • Publication Date:
      Date Created: 20241011 Date Completed: 20241127 Latest Revision: 20241130
    • Publication Date:
      20241202
    • Accession Number:
      PMC11602352
    • Accession Number:
      10.1016/j.whi.2024.09.001
    • Accession Number:
      39393957